Lyllana 0.0375 MG/Day Twice Weekly Transdermal Patch

RxCUI: 2399895
RxNorm name: Lyllana 0.0375 MG/Day Twice Weekly Transdermal Patch
Display name: Lyllana 0.0375 MG/Day Twice Weekly Transdermal Patch
Full name: Lyllana 0.0375 MG/Day Twice Weekly Transdermal Patch
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LYLLANA	ESTRADIOL	Amneal Pharmaceuticals LLC	09c472c6-a38a-4a3d-b048-6fefd52e2ad3	2024-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2399895

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
09c472c6-a38a-4a3d-b048-6fefd52e2ad3	Lyllana 0.0375 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00156 MG/HR Transdermal System [Lyllana] [SBD] · 84 HR Lyllana 0.00156 MG/HR Transdermal System [SY] · Lyllana 0.0375 MG/Day Twice Weekly Transdermal Patch [SY]	4	15	These highlights do not include all the information needed to use LYLLANA safely and effectively. See full prescribing information for LYLLANA. LYLLANA ® (estradiol transdermal system) Initial U.S. Approval: 1975	20240515